GERMANTOWN, Md., Feb. 10 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that Kenneth C. Carter, Ph.D., President and CEO and Gary Lessing, Executive Vice President and CFO are scheduled to present and participate in panel discussions at the Eighth Annual BIO CEO & Investor Conference, being held February 14-15, 2006 at the Waldorf-Astoria Hotel in New York.
On Tuesday, February 14th, Dr. Carter will provide a corporate overview and discuss the company’s recent progress at 3:30 pm EST. This presentation will be webcast live and will be accessible through Avalon’s website at http://www.avalonrx.com, under Investor Relations / Upcoming Presentations. An archive of the presentation will be available for 90 days following the presentation.
Also on February 14th at 4:00 pm EST, Mr. Lessing will participate in a business roundtable panel discussion entitled “Finance/Regulatory: Sarbanes-Oxley Blues -- Impact of Section 404 and Prescription for Reform”.
On Wednesday, February 15th at 3:30 pm EST, Dr. Carter will participate in a focus session panel discussion entitled “Genomics: Genomics is Back”. An archive of the panel session will be available on the BIO CEO website (http://ceo.bio.org/opencms/ceo/2006/index.jsp) by Thursday February 16th.
About Avalon Pharmaceuticals
Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. Avalon seeks to discover and develop novel therapeutics through the use of a comprehensive, innovative and proprietary suite of technologies based upon large-scale gene expression analysis which it calls AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is headquartered in Germantown, Maryland.
Contacts: Avalon Pharmaceuticals, Inc. Noonan Russo Gary Lessing Wendy Lau (Media) Executive Vice President and CFO Tel: (212) 845-4272 Tel: (301) 556-9900 Fax: (301) 556-9910 Jane Petrino (Investors) Email: info@avalonrx.com Tel: (212) 845-4274
Avalon Pharmaceuticals, Inc.
CONTACT: Gary Lessing, Executive Vice President and CFO of AvalonPharmaceuticals, Inc., +1-301-556-9900, Fax: +1-301-556-9910,info@avalonrx.com; or Media - Wendy Lau, +1-212-845-4272, or Investors -Jane Petrino, +1-212-845-4274, both of Noonan Russo
